CLIA Kit for Epithelial Neutrophil Activating Peptide 78 (ENA78)

CXCL5; SCYB5; Chemokine C-X-C-Motif Ligand 5; Small Inducible Cytokine Subfamily B(Cys-X-Cys),Member 5; Neutrophil-activating peptide ENA-78

Specificity

This assay has high sensitivity and excellent specificity for detection of Epithelial Neutrophil Activating Peptide 78 (ENA78).
No significant cross-reactivity or interference between Epithelial Neutrophil Activating Peptide 78 (ENA78) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Epithelial Neutrophil Activating Peptide 78 (ENA78) and the recovery rates were calculated by comparing the measured value to the expected amount of Epithelial Neutrophil Activating Peptide 78 (ENA78) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 97-104 101
EDTA plasma(n=5) 91-101 96
heparin plasma(n=5) 91-101 94

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Epithelial Neutrophil Activating Peptide 78 (ENA78) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Epithelial Neutrophil Activating Peptide 78 (ENA78) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Epithelial Neutrophil Activating Peptide 78 (ENA78) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 78-97% 78-98% 93-105% 89-97%
EDTA plasma(n=5) 92-105% 79-98% 93-105% 94-105%
heparin plasma(n=5) 95-105% 78-90% 91-98% 97-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
Substrate A 1×10mL Substrate B 1×2mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Journal of Biochemical and Molecular Toxicology Ameliorative Effects of Curcumin on Fibrinogen-Like Protein-2 Gene Expression, Some Oxido-Inflammatory and Apoptotic Markers in a Rat Model of l-Arginine-Induced Acute Pancreatitis. Pubmed:26862043
Journal of Biochemical and Molecular Toxicology Ameliorative Effects of Curcumin on Fibrinogen-Like Protein-2 Gene Expression, Some Oxido-Inflammatory and Apoptotic Markers in a Rat Model of l-Arginine-Induced Acute Pancreatitis pubmed:26862043
OncoTargets and Therapy The clinical significance of CXCL5 in non-small cell lung cancer. pubmed:29200871
Biochimie Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of β-catenin pathway Pubmed:29471001
Cancer Biology & Therapy Activation of CXCL5-CXCR2 axis promotes proliferation and accelerates G1 to S phase transition of papillary thyroid carcinoma cells and activates JNK and p38 … Pubmed: 30404567
Respiratory Research Phospholipase Cε plays a crucial role in neutrophilic inflammation accompanying acute lung injury through augmentation of CXC chemokine production from … Pubmed: 30634975
American Journal of Pathology Interleukin17–CXCR2 axis facilitates breast cancer progression by up-regulating neutrophil recruitment Pubmed: 31654638
Bioactive Materials Secretions from hypochlorous acid-treated tumor cells delivered in a melittin hydrogel potentiate cancer immunotherapy 34820587
Am J Cancer Res Differential expression profile of CXC-receptor-2 ligands as potential biomarkers in pancreatic ductal adenocarcinoma Pubmed:35141005
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPA860Ra01 Recombinant Epithelial Neutrophil Activating Peptide 78 (ENA78) Positive Control; Immunogen; SDS-PAGE; WB.
PAA860Ra01 Polyclonal Antibody to Epithelial Neutrophil Activating Peptide 78 (ENA78) WB; IHC; ICC; IP.
MAA860Ra21 Monoclonal Antibody to Epithelial Neutrophil Activating Peptide 78 (ENA78) WB; IHC; ICC; IP.
SEA860Ra ELISA Kit for Epithelial Neutrophil Activating Peptide 78 (ENA78) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA860Ra CLIA Kit for Epithelial Neutrophil Activating Peptide 78 (ENA78) Chemiluminescent immunoassay for Antigen Detection.
LMA860Ra Multiplex Assay Kit for Epithelial Neutrophil Activating Peptide 78 (ENA78) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.